Calmare Therapeutics (CTTC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2016 | 09-2016 | 06-2016 | 03-2016 | 12-2015 | |
| Sales | 384 | 501 | 215 | 70 | 544 |
| Cost of Goods | 914 | 570 | 467 | 474 | 542 |
| Gross Profit | -531 | -69 | -251 | -404 | 2 |
| Operating Expenses | 1,314 | 761 | 834 | 655 | 1,132 |
| Operating Income | -931 | -260 | -619 | -585 | -588 |
| Interest Expense | 277 | 394 | 470 | 293 | 283 |
| Other Income | 17 | 5 | -23 | 0 | 39 |
| Pre-tax Income | -1,191 | -648 | -1,112 | -878 | -832 |
| Net Income Continuous | -1,191 | -648 | -1,112 | -878 | -832 |
| Net Income | $-1,191 | $-648 | $-1,112 | $-878 | $-832 |
| EPS Basic Total Ops | -0.04 | -0.02 | -0.04 | -0.03 | -0.02 |
| EPS Basic Continuous Ops | -0.04 | -0.02 | -0.04 | -0.03 | -0.03 |
| EPS Diluted Total Ops | -0.04 | -0.02 | -0.04 | -0.03 | -0.02 |
| EPS Diluted Continuous Ops | -0.04 | -0.02 | -0.04 | -0.03 | -0.03 |
| EBITDA(a) | $-807 | $-14 | $-295 | $-437 | $-446 |